Abstract
Human glioma-derived cell lines previously determined by a microtiter chemotherapy assay to be either ‘sensitive’ or ‘resistant’ to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) were treated with BCNU (1–80 µg/ml) and observed using microcinematography, scanning electron microscopy, and transmission electron microscopy. Striking bleb formation and cell retraction were observed to occur in a dose-dependent relationship within minutes in the cells known to be BCNU-sensitive. At 15µg/ ml, 69% of cells showed blebs by 30 min, 87% by 90 min, and 100% by 4 hr. This activity was not seen in BCNU-resistant cells. These morphological changes occur at a time too early to be accounted for by the known BCNU mechanism of DNA alkylation and cross-link formation and suggest that cytoplasmic and/or membrane events may be significant initial events in the cytotoxic actions of BCNU.
Similar content being viewed by others
References
Kornblith PL, Szypko PE: Variations in response of human brain tumors to BCNU in vitro. J Neurosurg 48: 580–586, 1978.
Kornblith PL, Smith BH, Leonard LA: Response of cultured human brain tumors to nitrosoureas: correlation with clinical data. Cancer 47: 255–265, 1981.
Wheeler GP: Mechanism of action of alkylating agents: nitrosourea. In: Sartorelli AC, Johns DG (eds) Antineoplastic and immunosuppressive agents. Handbook of experimental pharmacology. Springer-Verlag, Berlin, New York, vol 38, pt 2, 1975, pp 65–84.
Wheeler GP: A review on studies on the mechanisms of action of nitrosoureas. In: Sartorelli AC (ed) Cancer chemotherapy. Am Chem Soc Symp, Washington D.C. vol 30, 1976, pp 87–119.
Kann HE Jr: Comparison of biochemical and biological effects of four nitrosoureas with differing carbamoylating activities. Cancer Res 38: 2363–2366, 1978.
Montgomery JA: Chemistry and structure-activity studies of the nitrosoureas. Cancer Treat Rep 60: 651–654, 1976.
Kohn KW: Interstrand cross-linking of DNA by 1,3-bis (2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-l-nitrosoureas. Cancer Res 37: 1450–1454, 1977.
Fornace AJ Jr, Kohn K Jr, Kann HE Jr: Inhibition of the ligase step of excision repair by 2-chloroethyl isocyanate, a decomposition product of 1,3-bis (2-chloroethyl)-1-nitrosourea. Cancer Res: 38: 1064–1069, 1978.
Kann HE Jr, Kohn KW, Lyles JM: Inhibition of DNA repair by the 1,3-bis (2-chloroethyl)-l-nitrosourea breakdown product, 2-chloroethyl isocyanate. Cancer Res 34: 398–402, 1974.
Erickson LC, Bradley MO, Kohn KW: Differential inhibition of the rejoining of x-ray induced DNA strand breaks in normal and transformed human fibroblasts treated with 1,3-bis(2-chloroethyl)-l-nitrosourea in vitro. Cancer Res 38: 672–677, 1978.
Erickson LC, Laurent G, Sharkey NA, Kohn KW: DNA cross-linking and monoadduct repair in nitrosourea-treated human tumor cells. Nature 288: 727–729, 1980.
Baril BB, Baril EF, Laszlo J, Wheeler GP: Inhibition of rat liver DNA polymerase by nitrosoureas and isocyanates. Cancer Res 35: 1–5, 1975.
Chuang RY, Laszlo J, Keller P: Effects of nitrosoureas on human DNA polymerase activities from acute and chronic granulocytic leukemia cells. Biochim Biophys Acta 425: 463–468, 1976.
Abelson HT, Karlan D, Pennman S: A comparison of the effects of alkylating agents 1,3-bis (2-chloroethyl)-1-nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, and nitrogen mustard on nuclear RNA synthesis and processing. Biochim Biophys Acta 349: 389–401, 1974.
Kann HE Jr, Kohn KW, Widerlite L, Gullion D: Effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and related compound on nuclear RNA metabolism. Cancer Res 34: 1982–1988, 1974.
Broome MG, Kornblith PL: Uptake and release of BCNU by human glial cells and effect of drug on macromolecular synthesis (abstract). In Vitro 14: 377, 1978.
Ludlum DB: Alkylating agents and the nitrosoureas. In: Becker FF (ed) Cancer: A comprehensive treatise. Plenum Press, New York, 1977, vol 5, pp 285–307.
Day RS III, Ziolkowski CHJ: Human brain tumor cell strains with deficient host-cell reactivation of N-methyl-N′-nitro-N nitrosoguanidine-damaged adenovirus 5. Nature 279: 797–799, 1979.
Day RS III, Ziolkowski CHJ, Scudiero DA, Meyer SA, Mattern MR: Human tumor cell strains defective in the repair of alkylation damage. Carcinogenesis 1: 21–32, 1980.
Black PMcL, Kornblith PL, Davison PF, Liszczak TM, Merk LP, Smith BH, McKeever PE, Quindlen EA: Immunological, biochemical, ultrastructural and electrophysiological characteristics of a human glioblastoma-derived cell culture line. J Neurosurg 56: 62–72, 1982.
Kornblith PL, Prieto A Jr, Pollen DA: Alterations in glial and mesenchymal tumor cell membrane resistance with heteroimmune and autologous sera. Ann NY Acad Sci 159: 585–590, 1969.
Lightbody J, Pfeiffer SE, Kornblith PL, Herschman H: Biochemically differentiated clonal human glial cells in tissue culture. J Neurobiol 1: 411–417, 1970.
McKeever PE, Quindlen EA, Banks MA, Williams U, Kornblith PL, Laverson S, Greenwood MA, Smith BH: Biosynthesized products of cultured neuroglial cells: I. Selective release of proteins by cells from human astrocytomas. Neurology 31: 1445–1452, 1981.
Trachtenberg MC, Kornblith PL, Hauptli J: Biophysical properties of cultured human glial cells. Brain Res 38: 279–298, 1972.
Weinstein RS, Kornblith PL: Ultrastructure of a cloned astrocytoma in tissue culture. Cancer 27: 1174–1181, 1971.
Wilson CB, Kornblith PL: Experimental brain tumors and experimental chemotherapy. In: Tower DB (ed) The nervous system. The clinical neuroscience. Raven Press, New York, 1975, vol 2, pp 175–181.
Shitara N, McKeever PE, Wang-PengJ, Smith BH, Schmidt S, Kornblith PL: Flowcytometric and cytogenetic analysis of human brain tumors. In preparation.
Coakham HB, Kornblith PL, Quindlen EA, Pollock LA, Wood WC, Hartnett LC: Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays. J Natl Cancer Inst 64: 223–233, 1980.
Kornblith PL, Coakham HB, Pollock LA, Wood WC, Green SB, Smith BH: Autologous serological responses in glioma patients: correlation with tumor grade and survival. Submitted to Cancer, 1982.
Levin VA, Hoffman W, Weinkam J: Pharmacokinetics of BCNU in man: a preliminary study of 20 patients. Cancer Treat Rep 62: 1305–1312, 1978.
DeVita VT, Denham C, Davidson JD, Oliverio VT: The physiological disposition of the carcinostatic 1,3-bis(2-chloroethyl)-l-nitrosourea (BCNU) in man and animals. Clin Pharmacol Ther 8:566–577, 1967.
Chatterji D, Greene R, Galleli J: Mechanisms of hydrolysis of halogenated nitrosoureas. J Pharm Sci 67: 1527–1532, 1978.
Russo R, Bartosek I, Piazza E, Santi A, Libretti A, Garatini S Differential pulse polarographic determination of BCNU pharmacokinetics in patients with lung cancer. Cancer Treat Rep 65:555–562, 1981.
Hanawalt PC, Setlow RB: Molecular mechanisms for repair of DNA. Plenum Press, New York 1975, p 843.
Altmann H, Schattauer F: DNA repair mechanisms. Schattauer-Verlag, Stuttgart, New York, 1972, pp 248.
Strauss B, Coyle M, Robbins M: Consequences of alkylation for the behavior of DNA. Ann NY Acad Sci 163: 765–787, 1969.
Allred LE, Porter KR: Morphology of normal and transformed cells. In: Hynes RO (ed) Surfaces of normal and malignant cells. Wiley, New York, 1979, pp 21–61.
Porter KR, Fonte VG, Weiss GE: A scanning microscope study of the topography of HeLa cells. Cancer Res 34: 1385–1394, 1974.
Taylor AC, Robbins E: Observations on microextensions from the surface of isolated vertebrate cells. Dev Biol 7: 660–673, 1963.
Bragina EE, Vasliliev JM, Gelfand IM: Formation of bundles of microfilaments during spreading of fibroblasts on the substrate. Exp Cell Res 97: 241–248, 1976.
Byers B, Abramson DH: Cytokinesis in HeLa: post-telephase delay and microtubule-associated motility. Protoplasma 66: 413–435, 1968.
Follett EAC, Goldman RD: The occurrence of microvilli during spreading and growth of BILK 21/03 fibroblasts. Exp Cell Res 59: 124–136, 1970.
Porter KR, Prescott DM, Frye J: Changes in surface morphology of Chinese hamster ovary cells curing the cell cycle. J Cell Biol 57: 815–836, 1973.
Bowman PD, Daniel CW: Aging of human fibroblasts in vitro surface features and behavior of aging WI-38 cells. Mech Ageing Dev 4: 147–158, 1975.
Erickson CA, Trinkaus JP: Microvilli and blebs as sources of reserve surface membrane during cell spreading. Exp Cell Res 99: 375–384, 1976.
Godman GC, Miranda AF, Deitch AD, Tanenbaum SW: Action of cytochalasin B on cells of established lines. III. Zeiosis and movements at the cell surface. J Cell Biol 64: 644–667, 1975.
Porter KR, Puck TT, Hsie AW, Kelley D: An electron microscope study of the effects of dibutyryl cyclic AMP on Chinese hamster ovary cells. Cell 2: 145–162, 1974.
Puck TT, Waldren CA, Hsie AW: Membrane dynamics in the action of dibutyryl adenosine 3′:5′-cyclic monophosphate and testosterone on mammalian cells. Proc Nat Acad Sci USA 69: 1943–1947, 1972.
Jewell S, Bellamo G, Thor H, Orrenius S, Smith M: Bleb formation in hepatocytes during drug metabolism is caused by disturbances in thiol and calcium ion homeostasis. Science 217: 1257–1259, 1982.
Nathan CF, Arrick BA, Murray HW, DeSantis MM, Cohn ZA: Tumor cell anti-oxidant defenses: Inhibition of the glutathione redox cycle enhances macrophage-mediated cytolysis. J Exp Med 153: 766–782, 1981.
Wheeler GP: Studies related to mechanisms of resistance to biological alkylating agents. Cancer Res 23: 1334–1349, 1963.
Author information
Authors and Affiliations
Additional information
Address for reprints: Barry H. Smith, M.D., Ph.D., Surgical Neurology Branch, NINCDS, NIH, Bldg. I OA, Rm. 3E68, Bethesda, MD 20205, USA
Rights and permissions
About this article
Cite this article
Smith, B.H., Vaughan, M., Greenwood, M.A. et al. Membrane and cytoplasmic changes in 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU)-sensitive and resistant human malignant glioma-derived cell lines. J Neuro-Oncol 1, 237–248 (1983). https://doi.org/10.1007/BF00165608
Issue Date:
DOI: https://doi.org/10.1007/BF00165608